VANFLYTA (quizartinib)

Medicine - Posted on Jun 18 2024

Active substance (DCI)

history (1)

Technical information

ATC code

Manufacturer

DAIICHI SANKYO FRANCE SAS

Presentation

VANFLYTA 17,7 mg, comprimé pelliculé
28 plaquettes aluminium de 1 comprimé (CIP : 34009 302 826 3 2)

VANFLYTA 26,5 mg, comprimé pelliculé
56 plaquettes aluminium de 1 comprimé (CIP : 34009 302 826 4 9)

All our publications

My account